Suppr超能文献

利用国家健康保险服务数据对韩国乳腺癌幸存者治疗模式的全国性分析。

Nationwide Analysis of Treatment Patterns for Korean Breast Cancer Survivors Using National Health Insurance Service Data.

机构信息

Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Department of Surgery, Soonchunhyang University Seoul Hospital, Seoul, Korea.

出版信息

J Korean Med Sci. 2018 Oct 1;33(44):e276. doi: 10.3346/jkms.2018.33.e276. eCollection 2018 Oct 29.

Abstract

BACKGROUND

The National Health Insurance Service (NHIS) established a healthcare claim database for all Korean citizens. This study aimed to analyze the NHIS data and investigate the patterns of breast cancer treatments.

METHODS

We constructed a retrospective female breast cancer cohort by analyzing annual incident cases. The annual number of newly diagnosed female breast cancer was compared between the NHIS data and Korea National Cancer Incidence Database (KNCIDB). The annual treatment patterns including surgery, chemotherapy, radiation therapy, endocrine therapy and targeted therapy were analyzed.

RESULTS

A total of 148,322 women with newly diagnosed invasive breast cancer during 2006-2014 was identified. The numbers of newly diagnosed invasive breast cancer cases were similar between the NHIS data and KNCIDB, which demonstrated a strong correlation ( = 0.995; < 0.001). The age distribution of the breast cancer cases in the NHIS data and KNCIDB also showed a strong correlation ( = 1.000; < 0.001). About 85% of newly diagnosed breast cancer patients underwent operations. Although the proportions of chemotherapy use have not changed during 2006-2014, the total number of chemotherapy prescriptions sharply increased during this period. The proportions of radiotherapy and anti-hormonal therapy increased. Among the anti-hormonal agents, tamoxifen was the most frequently prescribed medication, and letrozole was the most preferred endocrine treatment in patients aged ≥ 50 years.

CONCLUSION

Along with the increased breast cancer incidence in Korea, the frequencies of breast cancer treatments have increased. The NHIS data can be a feasible data source for future research.

摘要

背景

国家健康保险服务(NHIS)为所有韩国公民建立了一个医疗保健索赔数据库。本研究旨在分析 NHIS 数据并调查乳腺癌治疗模式。

方法

我们通过分析年度发病例数构建了一个回顾性女性乳腺癌队列。比较了 NHIS 数据和韩国国家癌症发病率数据库(KNCIDB)中每年新诊断的女性乳腺癌数量。分析了手术、化疗、放疗、内分泌治疗和靶向治疗等年度治疗模式。

结果

共确定了 2006-2014 年间 148322 例新诊断的浸润性乳腺癌女性。NHIS 数据和 KNCIDB 中新诊断浸润性乳腺癌病例数相似,相关性很强(=0.995;<0.001)。NHIS 数据和 KNCIDB 中乳腺癌病例的年龄分布也具有很强的相关性(=1.000;<0.001)。约 85%的新诊断乳腺癌患者接受了手术。尽管 2006-2014 年期间化疗的使用比例没有变化,但在此期间化疗处方的总数急剧增加。放疗和抗激素治疗的比例增加。在抗激素药物中,他莫昔芬是最常开的药物,而在≥50 岁的患者中,来曲唑是最受欢迎的内分泌治疗药物。

结论

随着韩国乳腺癌发病率的增加,乳腺癌治疗的频率也有所增加。NHIS 数据可以成为未来研究的可行数据来源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9226/6200903/c4e6365ef21d/jkms-33-e276-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验